PRESS RELEASE published on 10/31/2023 at 15:16, 2 years 1 month ago PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED
PRESS RELEASE published on 10/26/2023 at 12:50, 2 years 1 month ago EQS-Adhoc: PAION AG: Filing an application for the opening of insolvency proceedings
PRESS RELEASE published on 10/20/2023 at 07:30, 2 years 1 month ago PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights
PRESS RELEASE published on 10/19/2023 at 20:56, 2 years 1 month ago EQS-Adhoc: PAION AG to issue approximately 4.8 million shares in capital increase with subscription rights
PRESS RELEASE published on 10/13/2023 at 13:06, 2 years 1 month ago PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million
PRESS RELEASE published on 10/13/2023 at 12:57, 2 years 1 month ago EQS-Adhoc: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 2 months ago PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN
PRESS RELEASE published on 09/18/2023 at 15:26, 2 years 2 months ago Original-Research: PAION AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 08/31/2023 at 14:00, 2 years 3 months ago PAION receives UK MHRA approval of Byfavo® (remimazolam) for the induction and maintenance of general anesthesia in adults
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 3 months ago PAION AG reports financial results for the First Half-Year 2023
Published on 12/05/2025 at 02:35, 3 hours 35 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 10 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 5 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 10 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 19 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 45 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 55 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 59 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 26 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 9 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
